Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Nanopath
company
About
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$10.25M
Nanopath has raised a total of
$10.25M
in funding over 2 rounds. Their latest funding was raised on
Aug 9, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 9, 2022 | Series A | $10M | 1 |
Norwest Venture Partners
|
— | Detail |
| Dec 21, 2021 | Grant | $255.87K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Nanopath is funded by 2 investors.
Norwest Venture Partners
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Norwest Venture Partners
|
Yes | Series A |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
